| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Mei-Ping Qian, Mei-Rong Dong, Ming-Ming Han, Juan Li, Fang Kan. ABO blood types may affect transient neurological events after surgical revascularization in patients with moyamoya disease: a retrospective single center study. BMC anesthesiology. vol 23. issue 1. 2023-12-20. PMID:38114904. |
moyamoya disease (mmd) is a cerebrovascular disease with unknown cause. |
2023-12-20 |
2023-12-23 |
Not clear |
| Seong-Soo Lim, Sangshin Park, Byeong Ho Oh, Kiwook Jung, Jang-Whan Bae, Dae-Hwan Ba. RNF213 vasculopathy manifested in various forms within a family: A case report. Medicine. vol 102. issue 50. 2023-12-20. PMID:38115307. |
the ring finger protein 213 (rnf213) p.r4810k variant has been identified as being associated with moyamoya disease (mmd), a condition that is more prevalent in east asians. |
2023-12-20 |
2023-12-23 |
Not clear |
| Huiqin Li, Xiang Cao, Xinya Gu, Mengqi Dong, Lili Huang, Chenglu Mao, Shengnan Xia, Haiyan Yang, Xinyu Bao, Yongbo Yang, Yun X. GM-CSF Promotes the Development of Dysfunctional Vascular Networks in Moyamoya Disease. Neuroscience bulletin. 2023-12-19. PMID:38113014. |
moyamoya disease (mmd) is a chronic occlusive cerebrovascular disease with the development of a network of abnormal vessels. |
2023-12-19 |
2023-12-23 |
human |
| Keith Z X Toh, Ming Yi Koh, Enver D W Loh, Ching-Hui Sia, Yaofeng Chong, Leonard L L Yeo, Vijay K Sharma, Mervyn J R Lim, Benjamin Y Q Ta. Prevalence and Associations of Cognitive Impairment in Adult Patients with Moyamoya Disease: A Systematic Review and Meta-Analysis. Journal of Alzheimer's disease : JAD. 2023-12-18. PMID:38108354. |
cognitive impairment, and in the long term alzheimer's disease, vascular, or mixed dementia, are potential complications of moyamoya disease (mmd), of which the prevalence and associations are not well established. |
2023-12-18 |
2023-12-21 |
Not clear |
| Yasuyuki Kaku, Yuki Ohmori, Koki Kameno, Hiroki Uchikawa, Yushin Takemoto, Takayuki Kawano, Tatsuhiro Ishimura, Hiroyuki Uetani, Akitake Mukas. Inhalational Anesthesia Reduced Transient Neurological Events After Revascularization Surgery for Moyamoya Disease. Neurosurgery. 2023-12-18. PMID:38108408. |
the choice between inhalational and total intravenous anesthesia (tiva) in revascularization surgery for moyamoya disease (mmd) remains a topic of debate. |
2023-12-18 |
2023-12-21 |
Not clear |
| Duo Xu, Xinfeng Yu, Junwen Hu, Yannan Yu, Lin Wang, Biao Jiang, Minming Zhan. White matter hyperintensities in cholinergic pathways correlates of cognitive impairment in moyamoya disease. European radiology. 2023-12-13. PMID:38092950. |
to investigate the effect of cholinergic pathways damage caused by white matter hyperintensities (wmhs) on cognitive function in moyamoya disease (mmd). |
2023-12-13 |
2023-12-17 |
Not clear |
| Alexei Antonov, Anthony Terraciano, Muhammed Amir Essibayi, Kainaat Javed, David J Altschu. Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes. Neuropsychiatric disease and treatment. vol 19. 2023-12-13. PMID:38090021. |
current understanding of moyamoya disease (mmd) and associated neuropsychiatric outcomes. |
2023-12-13 |
2023-12-17 |
Not clear |
| Alexei Antonov, Anthony Terraciano, Muhammed Amir Essibayi, Kainaat Javed, David J Altschu. Current Understanding of Moyamoya Disease (MMD) and Associated Neuropsychiatric Outcomes. Neuropsychiatric disease and treatment. vol 19. 2023-12-13. PMID:38090021. |
moyamoya disease (mmd) is a rare cerebrovascular disorder characterized by the progressive narrowing and occlusion of the intracranial internal carotid arteries, leading to the formation of abnormal collateral vessels. |
2023-12-13 |
2023-12-17 |
Not clear |
| Jorge Rios-Zermeno, Abdul Karim Ghaith, Victor Gabriel El Hajj, Fatima Soltan, Elena Greco, Loizos Michaelides, Michelle P Lin, James F Meschia, Oluwaseun O Akinduro, Mohamad Bydon, Bernard R Bendok, Rabih G Taw. Extracranial - Intracranial Bypass for Moyamoya Disease: The Influence of Racial and Socioeconomic Disparities on Non-routine Discharge - A National Inpatient Sample Analysis. World neurosurgery. 2023-12-07. PMID:38061545. |
extracranial-intracranial (ec-ic) bypass is an established therapeutic option for moyamoya disease (mmd). |
2023-12-07 |
2023-12-17 |
Not clear |
| Thiparpa Thamamongood, Shoko Hara, Hiroyuki Akagawa, Motoki Inaji, Yoji Tanaka, Tadashi Nariai, Taketoshi Maehar. Synergistic Interaction of Thyroid Autoantibodies and Ring Finger Protein 213 Variant in Moyamoya Disease. Neurologia medico-chirurgica. 2023-12-06. PMID:38057092. |
recently, thyroid autoantibodies were found to be associated with moyamoya disease (mmd). |
2023-12-06 |
2023-12-10 |
Not clear |
| Peter Birkeland, Victoria Hansen, Vinosha Tharmabalan, Jens Lauritsen, Troels Nielsen, Thomas Truelsen, Sverre Rosenbaum, Paul von Weitzel-Mudersbac. Long-term stroke risk in Moyamoya disease. International journal of stroke : official journal of the International Stroke Society. 2023-12-04. PMID:37950387. |
moyamoya disease (mmd) is considered a progressive disease with an ongoing risk of recurrent stroke. |
2023-12-04 |
2023-12-10 |
Not clear |
| Aamuktha R Karla, Amélie Pinard, Maura L Boerio, Dimitri Hemelsoet, Simon J Tavernier, Michel De Pauw, Elke Vereecke, Stuart Fraser, Michael J Bamshad, Dongchuan Guo, Bert Callewaert, Dianna M Milewic. SAMHD1 compound heterozygous rare variants associated with moyamoya and mitral valve disease in the absence of other features of Aicardi-Goutières syndrome. American journal of medical genetics. Part A. 2023-12-02. PMID:38041217. |
one of the genes associated with ags, samhd1, has also been associated with a spectrum of cerebrovascular diseases, including moyamoya disease (mmd). |
2023-12-02 |
2023-12-10 |
Not clear |
| Woo-Keun Kwon, Chang-Min Yoo, Jang Hun Kim, Tae-Won Kim, An-Gi Kim, Min-Ho Hwang, Hyuk Cho. Role of human dural fibroblasts in the angiogenic responses of human endothelial cells: An in vitro dural model and the application of lab-on-a-chip for EDAS. Bioengineering & translational medicine. vol 8. issue 6. 2023-12-01. PMID:38023706. |
encephaloduroarteriosynangiosis (edas), an indirect anastomosis procedure, is widely accepted as a primary treatment for moyamoya disease (mmd) to improve collateral blood flow. |
2023-12-01 |
2023-12-07 |
human |
| Woo-Keun Kwon, Chang-Min Yoo, Jang Hun Kim, Tae-Won Kim, An-Gi Kim, Min-Ho Hwang, Hyuk Cho. Role of human dural fibroblasts in the angiogenic responses of human endothelial cells: An in vitro dural model and the application of lab-on-a-chip for EDAS. Bioengineering & translational medicine. vol 8. issue 6. 2023-12-01. PMID:38023706. |
encephaloduroarteriosynangiosis (edas), an indirect anastomosis procedure, is widely accepted as a primary treatment for moyamoya disease (mmd) to improve collateral blood flow. |
2023-11-29 |
2023-12-07 |
human |
| Jessica Kang, Chien-Nan Lee, Ming-Wei Lin, Shin-Yu Li. Safe delivery planning of patients with moyamoya disease in pregnancy: Case series of a single center. Taiwanese journal of obstetrics & gynecology. vol 62. issue 6. 2023-11-26. PMID:38008516. |
moyamoya disease (mmd) is a rare cerebral vascular disease and there is limited clinical experience for pregnant women. |
2023-11-26 |
2023-11-28 |
Not clear |
| Colin Kok Ann Teo, Yilong Zheng, Jeremy Bingyuan Lin, Hock Luen Teoh, Bernard Poon Lap Chan, Vijay Kumar Sharma, Kejia Teo, Vincent Diong Weng Nga, Tseng Tsai Ye. Outcomes after surgical revascularization for adult Moyamoya disease: A Southeast Asian tertiary centre experience. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. vol 119. 2023-11-25. PMID:38006812. |
there are numerous studies on the natural history and outcomes of adult moyamoya disease (mmd) in the literature, but limited data from southeast asian cohorts. |
2023-11-25 |
2023-11-28 |
Not clear |
| Chaojue Huang, Chong Huang, Xinli Zha. Predictive Factors for Seizures after Revascularization in Patients with Moyamoya Disease. World neurosurgery. 2023-11-23. PMID:37995995. |
moyamoya disease (mmd) is a rare and complex cerebrovascular disorder that is diagnosed through imaging studies, such as ct or mri, which show progressive narrowing of the terminal portion of the internal carotid arteries and the development of compensatory capillary collaterals. |
2023-11-23 |
2023-11-29 |
Not clear |
| Salman Ayub Jajja, Digbijay Kunwar, Shahroze Ahmed, Anum Akbar, Abdul Sattar Anjum, Sadia Anju. Moyamoya Disease in an Adolescent with Subarachnoid Hemorrhage: A Case Report. The International journal of neuroscience. 2023-11-23. PMID:37996399. |
moyamoya disease (mmd) is a rare condition where the internal carotid arteries and their branches progressively narrow and become blocked. |
2023-11-23 |
2023-11-29 |
Not clear |
| Qingbao Guo, Qian-Nan Wang, Jingjie Li, Simeng Liu, Xiaopeng Wang, Dan Yu, Zheng-Xing Zou, Gan Gao, Qian Zhang, Fang-Bin Hao, Jie Feng, Ri-Miao Yang, Minjie Wang, Heguan Fu, Xiangyang Bao, Lian Dua. Proteomic and metabolomic characterizations of moyamoya disease patient sera. Brain and behavior. 2023-11-14. PMID:37962021. |
the pathogenesis of moyamoya disease (mmd) is unclear. |
2023-11-14 |
2023-11-20 |
Not clear |
| Marilhia Cornejo, Ramit Singla, Savdeep Singh, Cheran Elangovan, Balaji Krishnaia. Adding a chapter to the literature: A rare encounter of unilateral Moyamoya disease with ipsilateral persistent trigeminal artery. eNeurologicalSci. vol 33. 2023-11-13. PMID:37954867. |
the coexistence of persistent trigeminal artery (pta) and moyamoya disease (mmd) has been reported. |
2023-11-13 |
2023-11-20 |
Not clear |